Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-3045 in healthy subjects.
Official title: A Phase Ⅰ, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-04-08
Completion Date
2025-10
Last Updated
2025-08-12
Healthy Volunteers
Yes
Conditions
Interventions
SHR-3045 Injection
SHR-3045 injection.
SHR-3045 Placebo Injection
SHR-3045 placebo injection.
Locations (1)
Shanghai General Hospital
Shanghai, Shanghai Municipality, China